Experience of Using of Valve Bronchial Block for Cavitary Pulmonary Mycobacteriosis Caused by Mycobacterium Kansasii in a Patient after Episodes of Pulmonary Embolism
https://doi.org/10.58838/2075-1230-2026-104-1-80-85
Abstract
The article presents a clinical case of cure of pulmonary mycobacteriosis (MB) with healing of a pathological cavity that developed as a result of Mycobacterium kansasii invasion. The combination of individually selected anti-mycobacteriosis chemotherapy and implantation of an endobronchial valve in the upper lobe bronchus of the right lung, draining the cavity, made it possible to achieve this result in a patient with a history of pulmonary embolism and other localizations of thrombosis, which was a contraindication for the lung resections.
About the Authors
G. M. Kuklina
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health
Russian Federation
Russian Federation
Galina M. Kuklina, Candidate of Medical Sciences, Pulmonologist
Build. 2 Dostoevsky St., Moscow, 127473;
Phone: +7 (495) 631-15-15
T. A. Naumova
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health
Russian Federation
Russian Federation
Tatiana A. Naumova, Endoscopist
Build. 2 Dostoevsky St., Moscow, 127473;
Phone: +7 (495) 631-15-15
N. G. Ershova
Pirogov Russian National Research Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Natalya G. Ershova, Candidate of Medical Sciences, Associate Professor of Phthisiology Department, Clinical Medicine Institute
1 Ostrovityanova St., Moscow, 117513;
Phone: +7 (495) 434-14-22
O. V. Lovacheva
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health
Russian Federation
Russian Federation
Olga V. Lovacheva, Doctor of Medical Sciences, Professor, Chief Researcher of Department of Differential Diagnosis and Treatment of Tuberculosis and Concurrent Infections
Build. 2 Dostoevsky St., Moscow, 127473;
Phone: +7 (495) 631-15-15
References
1. Guntupova L.D., Borisov S.E., Dreval P.A. et al. Pulmonary mycobacterioses: surgical aspects of diagnostics and treatment. Tuberculosis and Lung Diseases, 2016, no. 5, pp. 18-26. (In Russ.)
2. Klinicheskie rekomendatsii Tuberkulez u vzroslykh. [Clinical guidelines on tuberculosis in adults]. 2024, Available: https://cr.minzdrav.gov.ru/recomend/16_2 Accessed October 11, 2025
3. Lovacheva O.V., Russkikh A.E., Gracheva A.N., Panova A.E., Samoylova A.G., Vasilyeva I.A. Treatment of mycobacteriosis with lung destruction using long-term endobronchial valve implantation. Tuberculosis and Lung Diseases, 2022, vol. 100, no. 1, pp. 49-54. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-1-49-54
4. Bents S.J., Mercaldo R.A., Powell C., Henkle E., Marras T.K., Prevots D.R. Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010-2019. BMC Infect. Dis., 2024, vol. 24, no. 1, pp. 1094. https://doi.org/10.1186/s12879-024-09965-y
5. Carro М.L., Herranz B.E., Royo N.R. Respiratory infections due to nontuberculous mycobacterias. Med. Clin. (Barc), 2018, vol. 150, no. 5, pp. 191-197.
6. Dai J. Web-accessible database of hsp65 sequences from Mycobacterium reference strains. J. Clin. Microbiol., 2011, vol. 49, no. 6, pp. 2296-2303.
7. Daley C.L., Iaccarino J.M.Р., Lange C. et al. Treatment of nontuberculous mycobacterial pulmonary disease: An Official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin. Infect. Dis., 2020, vol. 71, no. 4, pp. 905-913. https://doi.org/10.1093/cid/ciaa1125
8. Daley C.L. Pulmonary non-tuberculous mycobacterial infections. Int. J. Tuberc. Lung Dis., 2010, vol. 14, no. 6, pp. 665-671.
9. Griffith D.E., Aksamit T., Brown-Elliott B.A. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med., 2007, no. 175, pp. 367-416.
10. Haworth C.S., Banks J., Capstick Т. et al. British Thoracic Society Guidelines for the Management of Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD). Thorax, 2017, vol. 72, sup l, pp. ii1– ii64.
11. Johnson M.M.Р., Odell J.A. Nontuberculous mycobacterial pulmonary infections. J. Thorac. Dis., 2014, vol. 6, no. 3, pp. 210-219.
12. Johnson T.M., Byrd T.F., Drummond W.K. et al. Contemporary pharmacotherapies for nontuberculosis mycobacterial infections: a narrative review. Infect. Dis., Ther., 2023. https://doi.org/10.1007/s40121-022-00750-5
13. Kim J-Y., Lee H.W., Yim J-J., Kwak N. Outcomes of adjunctive surgery in patients with nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis. Chest, vol. 163, no. 4, pp. 763-777. https://doi.org/10.1016/j.chest.2022.09.037
14. Koh W.J., Jeong B.H., Kim S.Y. et al. Mycobacterial characteristics and treatment outcomes in Mycobacterium abscessus lung disease. Clin. Infect. Dis., 2017, vol. 64, no. 3, pp. 309-316.
15. Koh W.J., Moon S.M., Kim S.Y. et al. Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype. Eur. Respir. J., 2017, vol. 50, no. 3, pp. 1602503.
16. Ku J.H., Henkle E., Aksamit T.R. Treatment of nontuberculous mycobacterial (NTM) pulmonary infection in the US bronchiectasis and NTM registry: treatment patterns, adverse events, and adherence to American Thoracic Society. Infectious Disease Society of America. Clin. Infect. Dis., 2023, vol. 76, no. 2, pp. 338-341. https://doi.org/10.1093/cid/ciac788
17. Nontuberculous Mycobacteriosis Control Committee of the Japanese Society for Tuberculosis; International Exchanging Committee of the Japanese Society for Tuberculosis. Guidelines for surgical therapy for pulmonary nontuberculous mycobacterial diseases. Kekkaku, 2011, vol. 86, no. 1, pp. 41-42.
18. Pathak K., Hart S., Lande L. Nontuberculous Mycobacteria Lung Disease (TM-LD): Current Recommendations on Diagnosis, Treatment, and Patient Management. Int. J. Gen. Med., 2022, no. 15, pp. 7619-7629. https://doi.org/10.2147/IJGM.S272690
19. Sherwood J.T., Mitchell J.D., Pomerantz M. Completion pneumonectomy for chronic mycobacterial disease. J. Thorac. Cardiovasc. Surg., 2005, vol. 129, no. 6, pp. 1258-1265.
20. Shiraishi Y., Nakajima Y., Katsuragi N. et al. Pneumonectomy for nontuberculous mycobacterial infections. Ann. Thorac. Surg., 2004, vol. 78, no. 2, pp. 399-403.
21. Treatment Guidelines. For the bronchiectasis and NTM Research Registry investigators. Clin. Infect. Dis., 2023, vol. 76, no. 2, pp. 338-341. https://doi.org/10.1093/cid/ciac788
22. Wallace R.J.Jr., Zhang Y., Brown-Elliott B.A. et al. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. J. Infect. Dis., 2002, vol. 186, no. 2, pp. 266-273.
Review
For citations:
Kuklina G.M., Naumova T.A., Ershova N.G., Lovacheva O.V. Experience of Using of Valve Bronchial Block for Cavitary Pulmonary Mycobacteriosis Caused by Mycobacterium Kansasii in a Patient after Episodes of Pulmonary Embolism. Tuberculosis and Lung Diseases. 2026;104(1):80-85. (In Russ.) https://doi.org/10.58838/2075-1230-2026-104-1-80-85
Views:
308
JATS XML
Email this article 